151 related articles for article (PubMed ID: 22487820)
21. Lipoprotein glomerulopathy: significance of lipoprotein and ultrastructural features.
Saito T; Oikawa S; Sato H; Sato T; Ito S; Sasaki J
Kidney Int Suppl; 1999 Jul; 71():S37-41. PubMed ID: 10412734
[TBL] [Abstract][Full Text] [Related]
22. Context-dependent and invariant associations between APOE genotype and levels of lipoproteins and risk of ischemic heart disease: a review.
Frikke-Schmidt R
Scand J Clin Lab Invest Suppl; 2000; 233():3-25. PubMed ID: 11317940
[TBL] [Abstract][Full Text] [Related]
23. Combined effects of apoE-CI-CII cluster and LDL-R gene polymorphisms on chromosome 19 and coronary artery disease risk.
Wang C; Zhou X; Ye S; Han D; Tan X; Zheng F; Shi Q
Int J Hyg Environ Health; 2006 May; 209(3):265-73. PubMed ID: 16459141
[TBL] [Abstract][Full Text] [Related]
24. Lipoprotein glomerulopathy: a new apolipoprotein E mutation with enhanced glomerular binding.
Sam R; Wu H; Yue L; Mazzone T; Schwartz MM; Arruda JA; Dunea G; Singh AK
Am J Kidney Dis; 2006 Mar; 47(3):539-48. PubMed ID: 16490634
[TBL] [Abstract][Full Text] [Related]
25. Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.
Cui T; Zhou X; Jin W; Zheng F; Cao X
Chin Med J (Engl); 2000 Apr; 113(4):340-4. PubMed ID: 11775232
[TBL] [Abstract][Full Text] [Related]
26. Clinical and genetic analysis of lipoprotein glomerulopathy patients caused by APOE mutations.
Yang M; Weng Q; Pan X; Hussain HMJ; Yu S; Xu J; Yu X; Liu Y; Jin Y; Zhang C; Li X; Ren H; Chen N; Xie J
Mol Genet Genomic Med; 2020 Aug; 8(8):e1281. PubMed ID: 32441489
[TBL] [Abstract][Full Text] [Related]
27. Lipoprotein glomerulopathy resulting from compound heterogeneous mutations of APOE gene: A case report.
Li Y; Chen J; Zou Y; Wang W; Li G
Medicine (Baltimore); 2022 Feb; 101(5):e28718. PubMed ID: 35119017
[TBL] [Abstract][Full Text] [Related]
28. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
29. Novel glomerular lipoprotein deposits associated with apolipoprotein E2 homozygosity.
Sakatsume M; Kadomura M; Sakata I; Imai N; Kondo D; Osawa Y; Shimada H; Ueno M; Miida T; Nishi S; Arakawa M; Gejyo F
Kidney Int; 2001 May; 59(5):1911-8. PubMed ID: 11318963
[TBL] [Abstract][Full Text] [Related]
30. Lipoprotein glomerulopathy in China.
Chen Y
Clin Exp Nephrol; 2014 Apr; 18(2):218-9. PubMed ID: 24165683
[TBL] [Abstract][Full Text] [Related]
31. [Discovery of a Chinese Tibetan patient with lipoprotein glomerulopathy due to APOE Osaka/Kurashiki variant].
Yang Z; Wu H; Hu Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Feb; 37(2):166-169. PubMed ID: 32034747
[TBL] [Abstract][Full Text] [Related]
32. [Study on apoE gene polymorphism and subclasses of serum high density lipoprotein in type IV hyperlipidemia].
Tian Y; Long SY; Xu YH; Fu MD; Zhang XM; Liu BW
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Feb; 22(1):96-8. PubMed ID: 15696494
[TBL] [Abstract][Full Text] [Related]
33. [A novel mutation of the alpha-L-iduronidase gene in a patient with mucopolysaccharidosis type I].
Dou W; Peng C; Zheng JK; Gu XF
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):136-9. PubMed ID: 17407067
[TBL] [Abstract][Full Text] [Related]
34. Signaling pathways of apoE and its role of gene expression in glomerulus diseases.
Zhou TB
J Recept Signal Transduct Res; 2013 Apr; 33(2):73-8. PubMed ID: 23384034
[TBL] [Abstract][Full Text] [Related]
35. [Association between apolipoprotein E gene polymorphism and the patients with persistent vegetative state in the Chinese].
Hu XF; Zhang XR; Xue A; Cao XR
Yi Chuan Xue Bao; 2002 Sep; 29(9):757-60. PubMed ID: 12561220
[TBL] [Abstract][Full Text] [Related]
36. Rapid and direct detection of apolipoprotein E genotypes using whole blood from humans.
Kim SW; Heo JH; Kim CH; Yoo DC; Won DH; Lee SG; Cho KJ; Song JH; Park SJ; Yang YG; Choi DW
J Toxicol Environ Health A; 2010; 73(21-22):1502-10. PubMed ID: 20954076
[TBL] [Abstract][Full Text] [Related]
37. Hereditary features, treatment, and prognosis of the lipoprotein glomerulopathy in patients with the APOE Kyoto mutation.
Hu Z; Huang S; Wu Y; Liu Y; Liu X; Su D; Tao Y; Fu P; Zhang X; Peng Z; Zhang S; Yang Y
Kidney Int; 2014 Feb; 85(2):416-24. PubMed ID: 24025644
[TBL] [Abstract][Full Text] [Related]
38. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels.
de Knijff P; van den Maagdenberg AM; Frants RR; Havekes LM
Hum Mutat; 1994; 4(3):178-94. PubMed ID: 7833947
[TBL] [Abstract][Full Text] [Related]
39. Significance of a novel apolipoprotein E variant, ApoE Osaka/Kurashiki, in lipoprotein glomerulopathy.
Saito T; Matsunaga A
J Atheroscler Thromb; 2011; 18(6):542-3. PubMed ID: 21670560
[No Abstract] [Full Text] [Related]
40. [Analysis of the interaction of the polymorphisms of presenilin-1 gene and ApoE gene in Alzheimerns disease].
Ma Q; Qian C; Liu Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Dec; 17(6):390-4. PubMed ID: 11110974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
